These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8105278)

  • 1. Cytopenia and fludarabine.
    Jaccard A; Oksenhendler E; Clauvel JP
    Lancet; 1993 Oct; 342(8878):1049-50. PubMed ID: 8105278
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of red cell aplasia in CLL with fludarabine.
    Ribeiro I; Tsatalas C; Catovsky D
    Leukemia; 1999 Nov; 13(11):1897. PubMed ID: 10557069
    [No Abstract]   [Full Text] [Related]  

  • 3. Refractory pure red-cell aplasia associated with B chronic lymphocytic leukemia successfully treated by fludarabine.
    Sandra S; Real E; Pastor E; Grau E
    Haematologica; 1999 Dec; 84(12):1154-5. PubMed ID: 10586218
    [No Abstract]   [Full Text] [Related]  

  • 4. Refractory pure red cell aplasia associated with B-CLL: successful treatment with a combination of fludarabine, cyclosporin A and erythropoietin.
    Shimoni A; Shvidel L; Klepfish A; Shtalrid M; Sigler E; Berrebi A
    Leukemia; 1999 Jan; 13(1):142-3. PubMed ID: 10049051
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acquired pure red cell aplasia in a patient with B cell chronic lymphocytic leukemia after fludarabine therapy].
    Tsuji T; Hirano T; Yamasaki H; Tuda H
    Rinsho Ketsueki; 2015 Jun; 56(6):705-10. PubMed ID: 26256883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunistic infections in patients with chronic lymphocytic leukemia following treatment with fludarabine.
    Sanders C; Perez EA; Lawrence HJ
    Am J Hematol; 1992 Apr; 39(4):314-5. PubMed ID: 1553963
    [No Abstract]   [Full Text] [Related]  

  • 7. Pure red-cell aplasia with fludarabine for chronic lymphocytic leukaemia.
    Leporrier M; Reman O; Troussard X
    Lancet; 1993 Aug; 342(8870):555. PubMed ID: 8102691
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful response to rituximab in a patient with pure red cell aplasia complicating chronic lymphocytic leukaemia.
    Batlle M; Ribera JM; Oriol A; Plensa E; Millá F; Feliu E
    Br J Haematol; 2002 Sep; 118(4):1192-3. PubMed ID: 12199808
    [No Abstract]   [Full Text] [Related]  

  • 9. Richter syndrome and fludarabine: a controversial relationship.
    Rossi D
    Leuk Lymphoma; 2013 Feb; 54(2):213-4. PubMed ID: 22897730
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe anemia caused by combination of autoimmune hemolysis, pure red cell aplasia and massive bone marrow infiltration in an elderly patient with chronic lymphocytic leukemia: successful treatment with rituximab.
    Smolej L; Belada D; Cermanová M; Maisnar V; Lunáková E
    Leuk Res; 2010 May; 34(5):e140-1. PubMed ID: 20053448
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-CD20 monoclonal antibody rituximab for the treatment of B-cell chronic lymphocytic leukemia-associated pure red cell aplasia.
    Pantelidou D; Tsatalas C; Margaritis D; Kaloutsi V; Spanoudakis E; Bourikas G
    Hematol J; 2004; 5(6):546-7. PubMed ID: 15570303
    [No Abstract]   [Full Text] [Related]  

  • 12. Fludarabine therapy in chronic lymphocytic leukemia-associated severe nephrotic syndrome.
    Abdel-Raheem MM; Jamil MG; Potti A; Gross GG
    Haematologica; 2000 Nov; 85(11):1224-5. PubMed ID: 11064479
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pure red cell aplasia associated with chronic lymphocytic leukaemic successfully treated with rituximab].
    Jiménez-Gonzalo FJ; Ríos-Herranz E; García-Donas Gabaldón G
    Med Clin (Barc); 2005 Nov; 125(18):717-8. PubMed ID: 16324487
    [No Abstract]   [Full Text] [Related]  

  • 14. [Selective aplasia of the red-cell series after fludarabine administration in a patient with chronic B-cell lymphatic leukemia].
    Antich Rojas J; Balaguer H; Cladera A
    Sangre (Barc); 1997 Jun; 42(3):254-6. PubMed ID: 9381277
    [No Abstract]   [Full Text] [Related]  

  • 15. Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature.
    Narra K; Borghaei H; Al-Saleem T; Höglund M; Smith MR
    Leuk Res; 2006 Jan; 30(1):109-14. PubMed ID: 16043218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia.
    Bastion Y; Coiffier B; Dumontet C; Espinouse D; Bryon PA
    Ann Oncol; 1992 Feb; 3(2):171-2. PubMed ID: 1606091
    [No Abstract]   [Full Text] [Related]  

  • 17. Crescentic glomerulonephritis associated with p-ANCA positivity in fludarabine-treated chronic lymphocytic leukaemia.
    Tisler A; Pierratos A; Lipton JH
    Nephrol Dial Transplant; 1996 Nov; 11(11):2306-8. PubMed ID: 8941597
    [No Abstract]   [Full Text] [Related]  

  • 18. [Progressive multifocal leukoencephalopathy in a patient with chronic lymphatic leukemia treated with fludarabine].
    Mata MI; Gardella S; del Mar Castellanos M; Ortiz MR
    Med Clin (Barc); 2000 Nov; 115(15):598-9. PubMed ID: 11141397
    [No Abstract]   [Full Text] [Related]  

  • 19. Fludarabine approved for use in chronic lymphocytic leukemia.
    Oncology (Williston Park); 1991 Jun; 5(6):20. PubMed ID: 1831638
    [No Abstract]   [Full Text] [Related]  

  • 20. Cryptococcus lung infection complicating fludarabine treatment in a chronic lymphocytic leukemia patient.
    Benetatos L; Hatzimichael E; Vassou A; Bourantas KL
    Leuk Res; 2007 Jan; 31(1):119-20. PubMed ID: 16620969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.